Cardio Diagnostics Holdings Inc. (CDIO)
NASDAQ · Healthcare
Cardio Diagnostics Holdings Inc. EBITDA 2021–2025
Cardio Diagnostics Holdings Inc. annual/quarterly ebitda history and growth rate from 2021 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cardio Diagnostics Holdings Inc. ebitda for the quarter ending March 31, 2026 was -1.8 M, a 12.25% increase year-over-year.
- Cardio Diagnostics Holdings Inc. ebitda for the twelve months ending March 31, 2026 was -6.0 M, a 38.55% decrease year-over-year.
- Cardio Diagnostics Holdings Inc. annual ebitda for 2025 was -6.4 M, a 23.09% decrease from 2024.
- Cardio Diagnostics Holdings Inc. annual ebitda for 2024 was -8.3 M, a 15.55% increase from 2023.
- Cardio Diagnostics Holdings Inc. annual ebitda for 2023 was -7.2 M, a 59.37% increase from 2022.
- Cardio Diagnostics Holdings Inc. annual ebitda for 2022 was -4.5 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cardio Diagnostics Holdings Inc. EBITDA — FAQ
Cardio Diagnostics Holdings Inc. (CDIO) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CDIO's ebitda history?
The chart and table above show Cardio Diagnostics Holdings Inc.'s ebitda by year and by quarter, including the growth rate.